Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Rapport Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +20 vs. Q3 2025
- Shares held
- 51.1M
- +1.81M (+3.7%) vs. Q3 2025
- Total value
- $1.55B
- +$86.4M (+5.9%) vs. Q3 2025
- New holders
- 40
- 51 more added
- Sold out
- 20
- 30 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $2.13B |
| Q1 2026 | 147 | $1.64B |
| Q4 2025 | 144 | $1.55B |
| Q3 2025 | 124 | $1.46B |
| Q2 2025 | 82 | $437.9M |
| Q1 2025 | 77 | $382.3M |
| Q4 2024 | 70 | $648.9M |
| Q3 2024 | 55 | $581.9M |
| Q2 2024 | 35 | $593.4M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Rapport Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 74,081 | $2.25M | 0.00% | +26,659+56.2% | Added |
| DAFNA Capital Management LLC | 75,000 | $2.28M | 0.53% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 78,659 | $2.41M | 0.00% | −3,672−4.5% | Reduced |
| Dimensional Fund Advisors LP | 83,487 | $2.53M | 0.00% | +72,157+636.9% | Added |
| EAM Investors, LLC | 85,555 | $2.60M | 0.29% | −1,717−2.0% | Reduced |
| Swedbank AB | 113,200 | $3.43M | 0.00% | +113,200 | New |
| TD Asset Management Inc | 115,190 | $3.49M | 0.00% | −21,824−15.9% | Reduced |
| Renaissance Technologies LLC | 118,814 | $3.60M | 0.01% | +83,514+236.6% | Added |
| Artia Global Partners LP | 138,508 | $4.20M | 0.68% | +73,900+114.4% | Added |
| Adage Capital Partners GP, L.L.C. | 150,000 | $4.55M | 0.01% | −300,000−66.7% | Reduced |
| Kennedy Capital Management, Inc. | 178,737 | $5.42M | 0.11% | +178,737 | New |
| Sio Capital Management, LLC | 185,265 | $5.62M | 0.93% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 194,200 | $5.89M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 201,825 | $6.12M | 0.00% | +47,651+30.9% | Added |
| Morgan Stanley | 210,331 | $6.38M | 0.00% | −64,237−23.4% | Reduced |
| Northern Trust Corp | 220,815 | $6.70M | 0.00% | +66,958+43.5% | Added |
| UBS Group AG | 226,360 | $6.87M | 0.00% | −331,713−59.4% | Reduced |
| Charles Schwab Investment Management Inc | 244,391 | $7.41M | 0.00% | +41,942+20.7% | Added |
| D. E. Shaw & Co., Inc. | 247,315 | $7.50M | 0.01% | +247,315 | New |
| Burkehill Global Management, LP | 250,000 | $7.58M | 0.50% | 00.0% | Unchanged |
| Prudential Financial Inc | 254,967 | $7.74M | 0.01% | +254,967 | New |
| Invesco Ltd. | 267,120 | $8.10M | 0.00% | +109,136+69.1% | Added |
| T. Rowe Price Investment Management, Inc. | 619,029 | $18.8M | 0.01% | −88,479−12.5% | Reduced |
| Perceptive Advisors LLC | 673,923 | $20.4M | 0.37% | +270,000+66.8% | Added |
| Geode Capital Management, LLC | 694,734 | $21.1M | 0.00% | +161,331+30.2% | Added |
| Siren, L.L.C. | 708,469 | $21.5M | 0.64% | −345,000−32.7% | Reduced |
| State Street Corp | 714,821 | $21.7M | 0.00% | +343,195+92.3% | Added |
| Alliancebernstein L.P. | 788,411 | $23.9M | 0.01% | −67,209−7.9% | Reduced |
| Price T Rowe Associates Inc | 881,609 | $26.7M | 0.00% | −220,782−20.0% | Reduced |
| UBS Asset Management Americas Inc | 952,371 | $28.9M | 0.01% | +60,113+6.7% | Added |
| TRV GP VI, LLC | 969,218 | $29.4M | 19.80% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 1,004,728 | $30.5M | 0.14% | +65,776+7.0% | Added |
| Vestal Point Capital, LP | 1,110,000 | $33.7M | 1.24% | +160,000+16.8% | Added |
| Baker Bros. Advisors LP | 1,547,090 | $46.9M | 0.27% | 00.0% | Unchanged |
| Johnson & Johnson | 1,784,517 | $54.1M | 9.75% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,817,757 | $55.2M | 0.00% | +191,219+11.8% | Added |
| Sofinnova Investments, Inc. | 1,904,408 | $57.8M | 2.49% | −43,171−2.2% | Reduced |
| BlackRock, Inc. | 2,431,862 | $73.8M | 0.00% | +863,781+55.1% | Added |
| Goldman Sachs Group Inc | 3,001,879 | $91.1M | 0.01% | +579,903+23.9% | Added |
| Cormorant Asset Management, LP | 3,027,521 | $91.9M | 5.21% | −165,000−5.2% | Reduced |
| Capital International Investors | 3,402,529 | $103.2M | 0.02% | 00.0% | Unchanged |
| ARCH Venture Management, LLC | 3,728,738 | $113.1M | 17.36% | 00.0% | Unchanged |
| FMR LLC | 7,111,865 | $215.8M | 0.01% | +194,870+2.8% | Added |
| TRV GP V, LLC | 7,135,233 | $216.5M | 50.44% | 00.0% | Unchanged |
| Franklin Resources Inc | 0 | $0 | 0.00% | −250,590−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −157,533−100.0% | Sold out |
| Fort Baker Capital Management LP | 0 | $0 | 0.00% | −81,644−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −71,807−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −69,570−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −57,148−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −46,223−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −45,130−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −28,972−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −11,149−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −9,830−100.0% | Sold out |
| State of Tennessee, Treasury Department | 0 | $0 | 0.00% | −5,400−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Bryn Mawr Trust Co | 0 | $0 | 0.00% | −4,822−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −3,728−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,475−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |